Back to courses

State of the Art Imaging in the Diagnosis and Management of Prostate Cancer

This is a Hybrid Course 


Staying abreast of the rapidly advancing field of prostate imaging is paramount to the successful staging and treatment of patients with prostate cancer. This one-day CME course, State of the Art Imaging in the Diagnosis and Management of Prostate Cancer, will discuss current and new developments in multiparametric MRI (mpMRI), MRI-ultrasound fusion biopsy, including transperineal biopsy, PSMA PET imaging, focal therapy treatment options, and other recent advances in imaging technology and diagnostics/therapeutics for prostate cancer. The course is designed to provide a focused, yet comprehensive advanced clinical review for practicing urologists, radiologists, medical oncologists, and radiation oncologists, as well as advanced practice providers. Participant learning and interaction will be encouraged through case reviews, question-and-answer sessions, and interaction with the course faculty.


Registration Type Tuition Fee
In-Person $250.00
Virtual $200.00

 

Target audience

This activity is intended for physicians, nurses, physician assistants, and other members of the healthcare team.

Learning objectives

Upon completion of this activity, participants will be able to:

  1. Define the most up-to-date imaging evaluation of patients with localized and advanced prostate cancer.
  2. Assess upcoming novel imaging techniques for the evaluation of prostate cancer.
  3. Describe imaging-based diagnostic and therapeutic procedural modalities including fusion biopsy and focal therapy.
  4. Apply the most current state-of-the-art mpMRI imaging in the care of prostate cancer patients or those with a suspicion of prostate cancer.
  5. Develop strategies for the healthcare team to incorporate MRI-ultrasound fusion prostate biopsy in clinical practice.
  6. Integrate the most current pathophysiological and pathological concepts into the interpretation of mpMRI.

FOR EXHIBIT SPACE, PLEASE CONTACT EBROOKS3@MGB.ORG

PDF icon State of the Art Imaging in the Diagnosis and Management of Prostate Cancer_Exhibitors.pdf


 

Registration instructions

Registration Type Tuition Fee
In-Person $250.00
Virtual $200.00

Cancellation Policy:
Registrations cancelled on or before October 18, 2024 will be refunded, less a $35 administrative fee. Registrations cancelled after October 18, 2024 will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.

Additional information

Massachusetts General Hospital Cancer Center & Mass General Brigham 

Faculty credentials

Course Directors

Adam S. Feldman, MD, MPH
Massachusetts General Hospital Cancer Center

Mukesh Harisinghani, MD
Massachusetts General Hospital

Faculty

Rory Cochran, MD, PhD
Massachusetts General Hospital

Alexander Cole, MD
Brigham and Women’s Hospital

Douglas Dahl, MD
Massachusetts General Hospital

Jason Efstathiou, MD, DPhil
Massachusetts General Hospital

Sophia Kamran, MD
Massachusetts General Hospital

Adam Kibel, MD
Brigham and Women’s Hospital

Richard J. Lee, MD
Massachusetts General Hospital Cancer Center

Avinash Maganty, MD
Massachusetts General Hospital Cancer Center

Keyan Salari, MD, PhD
Massachusetts General Hospital

Philip Saylor, MD
Massachusetts General Hospital Cancer Center

Minhaj Siddiqui, MD
Salem Hospital 

Baris Turkbey, MD
National Institute of Health

Robert Wang, MD
Massachusetts General Hospital

Matthew Wszolek, MD
Massachusetts General Hospital

Anthony Zietman, MD
Massachusetts General Hospital

Accreditation

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Mass General Brigham designates this activity for 7.25 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Program

7:00am Registration and Breakfast
7:40 Introduction and Welcome | Adam S. Feldman, MD, MPH & Mukesh Harisinghani, MD

Session 1: Imaging of the Prostate for Diagnosis

7:45

Multiparametric MRI – Current State of the Art and Future Directions | Mukesh Harisinghani, MD

8:15

MRI in the Patient with an Elevated PSA – Standard of Care | Robert Wang, MD

8:45

Utilization of Other Diagnostics/Biomarkers | Adam Kibel, MD

9:15

What to do After Negative Prostate MRI and Negative Fusion Biopsy | Adam Feldman, MD, MPH

9:35 Break

Session 2: Imaging of the Prostate for Treatment

10:00

Imaging for Staging and Treatment Planning — Surgery | ​​​Keyan Salari, MD, PhD

10:30

Imaging for Staging and Treatment Planning — Radiation | Jason Efstathiou, MD, DPhil

11:00

PSMA and Molecular Imaging of Prostate Cancer | Baris Turkbey, MD

11:30

Imaging of Advanced Disease | Philip Saylor, MD

12:00pm Lunch

Session 3: MRI-Guided Diagnostics and Treatment

12:45

Transperineal Prostate Biopsy | Douglas Dahl, MD

1:10

Utilization of MRI and Fusion Biopsy in the Active Surveillance Patient | Minhaj Siddiqui, MD

1:35

Utilization of Focal Therapy: When Is It Appropriate? | Alexander Cole, MD

2:00 Break

Session 4: Case-Based Panel Discussions

2:15

Diagnostic Dilemmas | Rory Cochran, MD, PhD; Avinash Maganty, MD; Minhaj Siddiqui, MD

2:45

The Active Surveillance Patient | Baris Turkbey, MD; Matthew Wszolek, MD; Anthony Zietman, MD

3:15

Locally Advanced Disease | Douglas Dahl, MD; Mukesh Harisinghani, MD; Sophia Kamran, MD

3:45

Metastatic Prostate Cancer | Rory Cochran, MD, PhD; Jason Efstathiou, MD, DPhil; Richard J. Lee, MD

4:15pm Thank you and Adjourn

 

Course Summary
  • Available credit
    7.25 AMA PRA Category 1 Credit™
    7.25 Nursing Contact Hours
    7.25 Participation
  • Formats
    Live
  • Categories
    Oncology
  • Event starts
    November 1, 2024, 7:40 am EDT
  • Event ends
    November 1, 2024, 4:15 pm EDT
  • Price
    $250.00
  • This course is closed.
Event location
  • Venue
    Joseph B. Martin Conference Center
    77 Avenue Louis Pasteur
    Boston, MA 02115 US
  • This is a live event.
Skip to content